Probiotics and the intestinal microflora: What impact on the immune system, infections and aging?

Current Nutrition and Food Science

Volumn 2, Issue 1, 2006, Pages 79-95

  Blaut, Mickaël ^a   Marteau, Philippe ^b   Miller, Gregory ^c   Antoine, Jean Michel ^d  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c National Dairy Council   (United States)

^d DANONE RESEARCH   (France)

Author keywords

Children; Cross talk; Gastro intestinal tract; Gut colonization; Immunity; Microflora; Probiotics; Research; Successful aging

Indexed keywords

PROBIOTIC AGENT;

AGING; ALLERGIC RHINITIS; ANAEROBIC BACTERIUM; ASTHMA; ATOPIC DERMATITIS; BACTEROIDES; BIOMEDICINE; CLINICAL TRIAL; DAIRY PRODUCT; DIARRHEA; DISEASE DURATION; FOOD INTAKE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRANSIT; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION RESISTANCE; INTESTINE FLORA; INTESTINE INFECTION; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS REUTERI; LACTOCOCCUS LACTIS; LACTOSE INTOLERANCE; MEDICAL RESEARCH; NUTRITIONAL HEALTH; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS; WELLBEING;

EID: 33745852628     PISSN: 15734013     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340106775472029     Document Type: Review

References (82)

1. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine", held in Paris, June 14, 2002. Am J Clin Nutr 2003; 78(4): 675-83.
2. Miller GD, Jarvis JK, McBean LD. The importance of meeting calcium needs with foods. JACN 2001; 20(2): 168S-85S.
3. Reid G, Sanders ME, Gaskins HR, et al. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003; 37(2): 105-18.
4. Bolotin A, Wincker P, Mauger S, et al. The complete genome sequence of the lactic acid bacterium lactococcus lactis ssp lactis ILI 403.Genomenes 2001; 11: 731-53.
5. Kleerebezem M, Boekhorst J, van Kranenburg R, et al. Complete genome sequence of lactobacillus plantarum WCFSI. Proc Natl Acad Sci USA 2003; 100: 1990-5.
6. Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273(5280): 1380-3.
7. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA 1999; 96(17): 9833-8.
8. Freitas M, Cayuela C, Antoine JM, Piller F, Sapin C, Trugnan G. A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells. Cell Microbiol 2001; 3(5): 289-300.
9. Freitas M, Axelsson LG, Cayuela C, Midtvedt T, Trugnan G. Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem Cell Biol 2002; 118 (2): 149-61.
10. Gewirtz AT, Rao AS, Simon PO Jr, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289(5484): 1560-3.
11. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291(5505): 881-4.
12. Ouelette AJ. Paneth cells and the innate immunity in the crypt microenvironment. Gastroenterology 1997; 113: 1779-84.
13. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1(2): 113-8.
14. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; 33 (Suppl 2): S17-25.
15. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109(4): 678-84.
16. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47(11): 2625-34.
17. Isolauri E, Kaila M, Arvola T, et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993; 33(6): 548-53.
18. Kaila M, Isolauri E, Virtanen E, Arvilommi H. Preponderance of IgM from blood lymphocytes in response to infantile rotavirus gastroenteritis. Gut 1992; 33(5): 639-42.
19. Hatakka K, Savilahti E, Ponka A et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001; 322(7298): 1327.
20. Isolauri E. Lecture in Danone International Probiotics Convention. 2003.
21. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357(9262): 1076-9.
22. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108(4): 516-20.
23. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108(1): 144-5.
24. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 (Suppl 1): S147-71.
25. Isolauri E, Rautava S, Kalliomaki M, Kirjavainen P, Salminen S. Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin Immunol 2002; 2(3): 263-71.
26. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99(2): 179-85.
27. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30(11): 1604-10.
28. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361(9372): 1869-71.
29. Guarner F, Malagelada JR. [Bacterial flora of the digestive tract]. Gastroenterol Hepatol 2003; 26 (Suppl 1): 1-5. Spanish.
30. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhea. Brit Med J 2002; 324: 1361-66.
31. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhea. Aliment Pharmacol Ther 2002; 16: 1461-67.
32. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, Neuhaus P, [Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial]. Z Gastroenterol 2002; 40(10): 869-76. German.
33. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89(9): 1103-7.
34. Borruel N, Carol M, Casellas F, et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002; 51(5): 659-64.
35. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354(9179): 635-9.
36. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124(5): 1202-9.
37. Prantera C, Scribano ML. Probiotics and Crohn's disease. Dig Liver Dis 2002; 34 (Suppl 2): S66-7.
38. Rafter J. Lactic acid bacteria and cancer: mechanistic perspective. Br J Nutr 2002; 88 (Suppl 1): S89-S94.
39. Monteleone G, Pender SL, Wathen NC, MacDonald TT. Interferon-alpha drives T cell-mediated immunopathology in the intestine. Eur J Immunol 2001; 31(8): 2247-55.
40. Nagata S, McKenzie C, Pender SL, et al. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol 2000; 165(9): 5315-21.
41. Cross ML, Mortensen RR, Kudsk J, Gill HS. Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol (Berl) 2002; 191(1): 49-53.
42. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78(3): 491-7.
43. Fang H, Elina T, Heikki A, Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 2000; 29(1): 47-52.
44. Benno Y, Endo K, Miyoshi H, Okada T, Koishi H, Mitsuoka T. Effect of rice fiber on human fecal microflora. Microbiol Immunol 1989; 33(5): 435-40.
45. Gavini F, Cayuela C, Antoine JM, et al. Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microb.Ecol.Health Dis 2001; 13: 35-42.
46. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48(2): 198-205.
47. Ouwehand AC, Isolauri E, Kirjavainen PV, Salminen SJ. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol Lett 1999; 172(1): 61-4.
48. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51(5): 448-54.
49. Saunier K, Dore J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis 2002; 34 Suppi 2: S19-24.
50. Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 2000; 3(1): 10-3.
51. Lesourd B, Mazari L, Ferry M. The role of nutrition in immunity in the aged. Nutr Rev 1998; 56: 113-25.
52. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care 2003; 6(1): 49-54.
53. Braga PC, Sala MT, Dal Sasso M, Pecile A, Annoni G, Vergani C. Age-associated differences in neutrophil oxidative burst (chemoluminescence). Exp Gerontol 1998; 33: 477-84.
54. McNerlan SE, Rea IM, Alexander HD, Morris TC. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol 1998; 18(1): 31-8.
55. Cakman I, Rohwer J, Schutz RM, Kirchner H, Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 1996; 87(3): 197-209.
56. + lymphocyte proportion is a consistent ageing phenotype. Mech Aging Dev 2002; 123: 145-53.
57. Shearer GM. Th1/Th2 changes in aging. Mech Ageing Dev 1997; 94(1-3): 1-5.
58. Walrand S, Moreau K, Caldefie F, et al. Specific and nonspecific immune responses to fasting and refeeding differ in healthy young adult and elderly persons. Am J Clin Nutr 2001; 74(5): 670-8.
59. Chandra RK. The relation between immunology, nutrition and disease in elderly people. Age Ageing 1990; 19(4): S25-31.
60. Beaufrere B, Boirie Y. Ageing and protein metabolism. Curr Opin Nutr Metab Care 1998; 1, 85-9.
61. Lesourd B. Protein undernutrition as the major cause of decreased immune function in the elderly: clinical and functional implications. Nutr Rev 1995; 53(4 Pt 2): S86-91; discussion S92-4.
62. Antoine JM, Turchet P, Meance S, Lucas C, Cayuela C. A fermented milk (Bifidobacterium animalis DN-173 010) is active on one gut function: Transit time. Biomed Environ Sci 2001; 14: 160-2.
63. Lesourd B. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr 1997; 66(2): 478S-84S.
64. Ouweland AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antoine Van Leeuwenhoek 2002; 82: 279-89.
65. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003; 7(2): 75-7.
66. Gil MT, Perez-Arellano I, Buesa J, Perez-Martinez G. Secretion of the rotavirus VP8* protein in Lactococcus lactis. FEMS Microbiol Lett 2001; 203(2): 269-74.
67. McBean LD and Miller GD. Allaying fears and fallacies about lactose intolerance. JADA 1998; 98(6): 671-676.
68. Jarvis JK and Miller GD. Overcoming the barrier of lactose intolerance to reduce health disparities. J Nat Med Assoc 2002; 94(2): 55-66.
69. Kolars JC, Levitt MD, Aouji M, Savaiano DA. Yogurt; an autodisgesting source of lactose. N Engl J Med 1984; 310(1): 1-3.
70. Arrigoni E, Marteau. P. Tolerance and absorption of lactose from milk and yogurt during short-bowel syndrome in humans. Am J Clin Nutr 1994; 60: 926-9.
71. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999; 53(3): 179-84.
72. Pedone CA, Arnaud CC, Postaire ER, Bouley CF, Reinert P. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 2000; 54(9): 568-71.
73. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Br J Med 2001; 322: 1327-9.
74. Bouvier M, Méance S, Bouley C, Berta JL, Grimaud JC. Effects of consumption of a milk fermented with the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans. Biosci Microflora, 2001; 20: 43-8.
75. Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16(3): 587-93.
76. Felley CP, Corthesy-Theulaz I, Rivero JL, et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13(1): 25-9.
77. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy a pilot study. Digestion 2001; 63(1): 1-7.
78. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003; (171): re3.
79. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003; 17(5): 725-40.
80. Strachan DP. Hay fever, hygiene, and household size. Br J Med 1989; 299(6710): 1259-60.
81. Shanahan F. Probiotics: a perspective on problems and pitfalls. Scand J Gastroenterol 2003; Suppl. (237): 34-6. Review.
82. Nutrition & Health Collection.Fermented foods & healthy digestive collection; 30-34. Ed. John Libbey Eurotext 2001; ISBN: 2-7420-0365-7.